Therefore, this study aimed to characterize the expression patterns of CYP1B1 protein using immunohistochemistry in bone sarcomas, with a special focus on osteosarcoma and chondrosarcoma, and evaluate its association with relevant clinicopathological characteristics and patient outcomes. Here, CYP1B1 is linked to bone sarcoma.